Clinical Trials List
2019-06-01 - 2024-07-31
Phase III
Terminated7
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 王樹吉 Division of Urology
- Cheng-Che Chen Division of Urology
- 熊小澐 Division of Radiology
- Jian-Ri Li Division of Urology
- Chuan-Shu Chen Division of Urology
- 洪晟鈞 Division of Urology
- 裘坤元 Division of Urology
- Chia-Yen Lin Division of Urology
- Cheng-Kuang Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tzeon-jye Chiou Division of Hematology & Oncology
- 潘競成 Division of General Surgery
- 沈書慧 Division of Radiology
- Yen-Hwa Chang Division of Urology
- Jiun-I Lai Division of Hematology & Oncology
- Chih-Chieh Lin Division of Urology
- Yi-Hsiu Huang Division of Urology
- Tzu-chun Wei Division of Urology
- Tzu-Ping Lin Division of Urology
- Mu-Hsin Chang Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Kwang-Yu Chang Division of Urology
- Yuh-Shyan Tsai Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ying-Chun Shen Division of Hematology & Oncology
- - - Division of Urology
- FU-JEN HSUEH Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- - - Division of Urology
- YU-CHUAN LU Division of Urology
- CHUNG-HSIN CHEN Division of Urology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tai-Jan Chiu Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 林偉哲 Division of Radiology
- 湯禹舜 Division of Radiology
- Shau-Hsuan Li Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Han Chang Division of General Surgery
- Chi-Rei Yang Division of Urology
- Ching-Chan Lin Division of Hematology & Oncology
- Yi-Huei Chang Division of Urology
- Su-Peng Yeh Division of General Internal Medicine
- Hsi-Chin Wu Division of Urology
- Chi-Ping Huang Division of Urology
- Po-Fan Hsieh Division of Urology
- Wei-Ching Lin Division of Radiology
- 陳冠亨 Division of Urology
- Po-Jen Hsiao Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hui-Ching Wang Division of Hematology & Oncology
- Ching-Chia Li Division of Urology
- Tsung-Yi Huang Division of Urology
- 阮雍順 Division of Urology
- Sheng-Chen Wen Division of Urology
- Hsiang Ying Lee Division of Urology
- 黃俊農 Division of Urology
- Yung-Chin Lee Division of Urology
- Hung-Lung Ke Division of Urology
- Tsu-Ming Chien Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
694 participants
